The authors concluded that the urinary NGF could be a useful biomarker to diagnose overactive bladder and a potential biomarker to differentiate cases with and without associated urinary incontinence, but it could not be used to differentiate overactive bladder from painful bladder syndrome (46). This evidence concerns the gene NGF and overactive bladder.